Your Location：
Home >
Browse articles >
Mechanism of Huangqi Chifengtang in Treating Atherosclerosis Based on 16S rRNA Sequencing and Metabolomics
Mechanism of Huangqi Chifengtang in Treating Atherosclerosis Based on 16S rRNA Sequencing and Metabolomics
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 13, Pages: 94-103(2025)
DOI： 10.13422/j.cnki.syfjx.20240718
Accepted：10 November 2024
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 1 ) Tabs( 7 )
References
Publication Info
Metrics
381
Views
311
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Iron Homeostasis Imbalance Promotes Atherosclerosis and Therapeutic Mechanisms of Traditional Chinese Medicine
Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Differentiation and Treatment of Vulnerable Atherosclerotic Plaque Based on "Collateral Disease" Theory
Effect and Molecular Mechanisms of Danlou Tablet on Hepatic Lipid Deposition in ApoE-/- Atherosclerotic Mice Through Regulation of SIRT6/CREB/Nor1 Signaling Pathway-mediated Autophagy
Molecular Mechanisms and Research Progress of Traditional Chinese Medicine Intervention in Diabetic Foot Ulcers Based on Regulation of Inflammation-oxidative Stress Axis
Related Author
WANG Maohong
XIONG Jianhua
ZHANG Hao
YAN Xiaohong
WAN Qiang
XIANG Jiao
LUO Jieying
LIAO Daiyuan
Related Institution
Jiangxi University of Chinese Medicine
The Affiliated Hospital of Jiangxi University of Chinese Medicine
School of Chinese Materia Medica，Guangzhou University of Chinese Medicine
Baiyunshan Pharmaceutical General Factory， Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.
Guangzhou Caizhilin Pharmaceutical Co. Ltd.
Intro
Map
Chat
